Concomitant presence of endothelial nitric oxide 894T and angiotensin II-converting enzyme D alleles are associated with diabetic nephropathy in a Kurdish population from Western Iran

Nephrology

Volumn 17, Issue 2, 2012, Pages 175-181

  Rahimi, Zohreh ^a,b   Vaisi Raygani, Asad ^b   Rahimi, Ziba ^a   Parsian, Abbas ^c  

^a KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

Author keywords

ACE I D; eNOS G894T; macroalbuminuria; microalbuminuria; type 2 diabetes mellitus

Indexed keywords

ANGIOTENSIN CONVERTING ENZYME 2; CAPTOPRIL; ENDOTHELIAL NITRIC OXIDE SYNTHASE;

ADULT; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIABETIC PATIENT; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE COURSE; DNA POLYMORPHISM; ENZYME ACTIVITY; ENZYME SYNTHESIS; FEMALE; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENETIC PREDISPOSITION; GENOTYPE; HUMAN; IRAN; MACROALBUMINURIA; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT;

AGED; ALBUMINURIA; ANALYSIS OF VARIANCE; CHI-SQUARE DISTRIBUTION; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IRAN; LOGISTIC MODELS; MALE; MIDDLE AGED; NITRIC OXIDE SYNTHASE TYPE III; ODDS RATIO; PEPTIDYL-DIPEPTIDASE A; PHENOTYPE; POLYMORPHISM, GENETIC; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS;

EID: 84856178528     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2011.01533.x     Document Type: Article

References (35)

1. Felehgari V, Rahimi Z, Mozafari H, Vaisi-Raygani A,. ACE gene polymorphism and serum ACE activity in Iranian type II diabetic patients with macroalbuminuria. Mol. Cell. Biochem. 2011; 346: 23-30.
2. Palomo-Pinon S, Gutierrez-Rodrigues ME, Diaz-Flores M, et al,. DD genotype of angiotensin-converting enzyme in type 2 diabetes mellitus with renal disease in Mexican Mestizos. Nephrology 2009; 14: 235-9.
3. Ezzidi I, Mtiraoui N, Kacem M, Chaieb M, Mahjoub T, Almawi WY,. Identification of specific angiotensin-converting enzyme variants and haplotypes that confer risk and protection against type 2 diabetic nephropathy. Diabetes Metab. Res. Rev. 2009; 25: 717-24.
4. Prabhakar SS,. Role of nitric oxide in diabetic nephropathy. Semin. Nephrol. 2004; 24: 333-44. (Pubitemid 38900633)
5. Ahluwalia TS, Ahuja M, Rai TS, et al,. Endothelial nitric oxide synthase gene haplotypes and diabetic nephropathy among Asian Indians. Mol. Cell. Biochem. 2008; 314: 9-17.
6. Zintzaras E, Papathanasiou AA, Stefanidis I,. Endothelial nitric oxide synthase gene polymorphisms and diabetic nephropathy: A HuGE review and meta-analysis. Genet. Med. 2009; 11: 695-706.
7. White KE, Bilous RW,. Type 2 diabetic patients with nephropathy show structural-functional relationships that are similar to type 1 disease. J. Am. Soc. Nephrol. 2000; 11: 1667-73.
8. Miyamoto Y, Saito Y, Kajiyama N, et al,. Endothelial nitric oxide synthase gene is positively associated with essential hypertension. Hypertension 1998; 32: 3-8. (Pubitemid 28324117)
9. Jacobsen PK,. Preventing end stage renal disease in diabetic patients: Genetic aspect (part I). J. Renin Angiotensin Aldosterone Syst. 2005; 6: 1-14. (Pubitemid 40796843)
10. Nikzamir A, Nakhjavani M, Esteghamati A, et al,. Correlates of ACE activity in macroalbuminuric type 2 diabetic patients treated with chronic ACE inhibition. Nephrol. Dial. Transplant. 2008; 23: 1274-7. (Pubitemid 351767484)
11. Kumar A, Mohindru K, Sehajpal PK,. Angiotensin-I converting enzyme polymorphism and diabetic nephropathy in North India. Int. J. Hum. Genet. 2005; 5: 279-83.
12. Hadjadj S, Tarnow L, Forsblom C, et al,. Association between angiotensin-converting enzyme gene polymorphisms and diabetic nephropathy: Case-control, haplotype, and family-based study in three European populations. J. Am. Soc. Nephrol. 2007; 18: 1284-91. (Pubitemid 46536914)
13. Shin Shin Y, Baek SH, Chang KY, et al,. Relations between eNOS Glu298Asp polymorphism and progression of diabetic nephropathy. Diabetes Res. Clin. Pract. 2004; 65: 257-65. (Pubitemid 39141182)
14. Zanchi A, Moczulski DK, Hanna LS, et al,. Risk of advanced diabetic nephropathy in type 1 diabetes is associated with endothelial nitric oxide synthase gene polymorphism. Kidney Int. 2000; 57: 405-13. (Pubitemid 30430632)
15. Ezzidi I, Mtiraoui N, Mohamed MB, et al,. Association of endothelial nitric oxide synthase Glu298Asp, 4b/a, and 786T-C gene variants with diabetic nephropathy. J. Diabetes Complications 2008; 22: 331-8.
16. Noiri E, Satoh H, Taguchi J, et al,. Association of eNOS Glu298Asp polymorphism with end-stage renal disease. Hypertension 2002; 40: 535-40.
17. Thaha M, Pranawa W, Yogiantoro M, et al,. Association of endothelial nitric oxide synthase Glu298Asp polymorphism with end-stage renal disease. Clin. Nephrol. 2008; 70: 144-54.
18. Nagase S, Suzuki H, Wang Y, et al,. Association of ecNOS gene polymorphisms with end stage renal diseases. Mol. Cell. Biochem. 2003; 244: 113-18. (Pubitemid 36411061)
19. Ruggenenti P, Bettinaglio P, Pinares F, Remuzzi G,. Angiotensin converting enzyme insertion/deletion polymorphism and renoprotection in diabetic and nondiabetic nephropathies. Clin. J. Am. Soc. Nephrol. 2008; 3: 1511-25.
20. Rahimi Z, Felehgari V, Rahimi M, et al,. The Frequency of factor V Leiden mutation, ACE gene polymorphism, serum ACE activity and response to ACE inhibitor and angiotensin II receptor antagonist drugs in Iranians type II diabetic patients with microalbuminuria. Mol. Biol. Rep. 2011; 38: 2117-23.
21. WHO Study Group Report of a WHO Consultation. Part 1. Diagnosis and Classification of Diabetes Mellitus. Geneva: World Health Organization, 1999.
22. American Diabetes Association. Nephropathy in diabetes. Diabetes Care 2004; 27: S79-S83.
23. Rahimi Z, Muniz A, Akramipour R, et al,. Haplotype analysis of beta thalassemia patients in Western Iran. Blood Cells Mol. Dis. 2009; 42: 140-43.
24. Nakhjavani M, Esfahnian F, Jahanshahi A, et al,. The relationship between the insertion/deletion polymorphism of the ACE gene and hypertension in Iranian patients with type 2 diabetes. Nephrol. Dial. Transplant. 2007; 22: 2549-53. (Pubitemid 47365519)
25. Vaisi-Raygani A, Rahimi Z, Tavilani H, Pourmotabbed T,. Butyrylcholinesterase K variant and the APOE-e4 allele work in synergy to increase the risk of coronary artery disease especially in diabetic patients. Mol. Biol. Rep. 2010; 37: 2083-91.
26. Zintzaras E,. The generalized odds ratio as a measure of genetic risk effect in the analysis and meta-analysis of association studies. Stat. Appl. Genet. Mol. Biol. 2010; 9: 1-12.
27. Wang Y, Ng MC, So WY, et al,. Prognostic effect of insertion/deletion polymorphism of the ace gene on renal and cardiovascular clinical outcomes in Chinese patients with type 2 diabetes. Diabetes Care 2005; 28: 348-54. (Pubitemid 40170938)
28. Marre M, Bouhanick B, Berrut G, et al,. Renal changes on hyperglycemia and angiotensin-converting enzyme in type 1 diabetes. Hypertension 1999; 33: 775-80. (Pubitemid 29140433)
29. Hadjadj S, Fumeron F, Roussel R, et al,. Prognostic value of the insertion/deletion polymorphism of the ACE gene in type 2 diabetic subjects. Diabetes Care 2008; 31: 1847-52.
30. Bellini MH, Figueira MN, Piccoli MF, et al,. Association of endothelial nitric oxide synthase gene intron 4 polymorphism with end-stage renal disease. Nephrology 2007; 12: 289-93. (Pubitemid 46718205)
31. Mollsten A, Lajer M, Jorsal A, Tarnow L,. The endothelial nitric oxide synthase gene and risk of diabetic nephropathy and development of cardiovascular disease in type 1 diabetes. Mol. Genet. Metab. 2009; 97: 80-84.
32. Pieper GM,. Review of alterations in endothelial nitric oxide production in diabetes: Protective role of arginine on endothelial dysfunction. Hypertension 1998; 31: 1047-60. (Pubitemid 28191496)
33. Bank N, Aynedjian HS,. Role of EDRF (nitric oxide) in diabetic renal hyperfiltration. Kidney Int. 1993; 43: 1306-12. (Pubitemid 23161417)
34. Fairchild TA, Fulton D, Fontana JT, Gratton J-P, McCabe TJ, Sessa WC,. Acidic hydrolysis as a mechanism for the cleavage of the Glu298Asp variant of human endothelial nitricoxide synthase. J. Biol. Chem. 2001; 276: 26674-9.
35. Tesauro M, Thompson WC, Rogliani P, Qi L, Chaudhary PP, Moss J,. Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: Cleavage of proteins with aspartate vs. glutamate at position 298. Proc. Natl Acad. Sci. U.S.A. 2000; 97: 2832-5. (Pubitemid 30159257)